1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Monosol Rx, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Monosol Rx, LLC (Monosol) is a pharmaceutical company that discovers, develops and commercializes thin film pharmaceutical products. The company uses PharmFilm technology to provide drugs in films. It offers products that include zuplenz, suboxone, rizatriptan, diazepam, flu vaccine and others. Monosol also provide nutraceutical and various consumer products, packaging solutions, and drug products for the treatment of opioid dependence, nausea and vomiting. The company works in partnership with other pharmaceutical and marketing companies to develop pharmaceutical products from the pre-clinical to late stage phases. It has manufacturing facility in Indiana, the US. Monosol is headquartered in Warren, New Jersey, the US.

Monosol Rx, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Monosol Rx, LLC - Pharmaceuticals and Healthcare - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 5
Monosol Rx, LLC, Pharmaceuticals and Healthcare Deals By Type, 2010 to YTD 2016 6
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 7
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Monosol Rx, LLC, Medical Devices Deals, 2010 to YTD 2016 9
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals Summary, 2010 to YTD 2016 10
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deal Details 11
Asset Purchase 11
Monosol Acquires Buccal Film Patent From Fuisz Pharma 11
Partnerships 13
Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine 13
Monosol Rx Terminates Agreement with KemPharm 15
MonoSol Rx Expands Co-Development Agreement With KemPharm 16
Midatech Expands Collaboration Agreement With MonoSol Rx 18
MonoSolRx Expands Collaboration Agreement With APR Applied Pharma 19
Licensing Agreements 20
Cynapsus Therapeutics Enters into Licensing Agreement with MonoSol Rx 20
Monosol Rx Enters into Licensing Agreement with Galena Biopharma for Zuplenz 21
Monosol Rx Enters Into Licensing Agreement With Vestiq Pharma For Zuplenz 22
MonoSol Terminates Licensing Agreement With Strativa Pharma For Zuplenz 23
Monosol Rx, LLC - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations and Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Key Facts 1
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 5
Monosol Rx, LLC, Pharmaceuticals and Healthcare Deals By Type, 2010 to YTD 2016 6
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 7
Monosol Rx, LLC, Deals By Therapy Area, 2010 to YTD 2016 8
Monosol Rx, LLC, Medical Devices Deals, 2010 to YTD 2016 9
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals Summary, 2010 to YTD 2016 10
Monosol Acquires Buccal Film Patent From Fuisz Pharma 11
Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine 13
Monosol Rx Terminates Agreement with KemPharm 15
MonoSol Rx Expands Co-Development Agreement With KemPharm 16
Midatech Expands Collaboration Agreement With MonoSol Rx 18
MonoSolRx Expands Collaboration Agreement With APR Applied Pharma 19
Cynapsus Therapeutics Enters into Licensing Agreement with MonoSol Rx 20
Monosol Rx Enters into Licensing Agreement with Galena Biopharma for Zuplenz 21
Monosol Rx Enters Into Licensing Agreement With Vestiq Pharma For Zuplenz 22
MonoSol Terminates Licensing Agreement With Strativa Pharma For Zuplenz 23
Monosol Rx, LLC, Key Competitors 24
Monosol Rx, LLC, Key Employees 25
Monosol Rx, LLC, Other Locations 26

List of Figures
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 1
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 1
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 1
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 5
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 6
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 7
Monosol Rx, LLC, Pharmaceuticals and Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Monosol Rx, LLC, Medical Devices Deals, 2010 to YTD 2016 9

Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016 Summary Global Markets ...

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Iduronate 2 Sulfatase (Alpha L Iduronate ...

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016 Summary Global Markets ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.